TrialJAMA network open2023

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Aditi R Saxena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.